| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-13 | Hollywood Mark EVP & Chief Operating Officer | Sale | -6,120 | -4.40%132,913 | $22.67 | $138,762 | View SEC filing | |
| 2026-01-12 | Smith Jeffrey T L EVP & Chief Medical Officer | Sale | -9,310 | -25.85%26,708 | $22.67 | $211,090 | View SEC filing | |
| 2026-01-12 | Moore Paul Andrew Chief Scientific Officer | Sale | -9,560 | -16.47%48,497 | $22.67 | $216,759 | View SEC filing | |
| 2026-01-12 | Galbraith Kenneth Chair & CEO | Sale | -30,424 | -11.83%226,842 | $22.67 | $689,819 | View SEC filing | |
| 2026-01-05 | Smith Jeffrey T L EVP & Chief Medical Officer | Sale | -10,538 | -36.48%18,352 | $25.10 | $264,471 | View SEC filing | |
| 2026-01-05 | Galbraith Kenneth Chair & CEO | Sale | -54,343 | +6.81%193,266 | $25.10 | $1,363,841 | View SEC filing | |
| 2026-01-05 | Moore Paul Andrew Chief Scientific Officer | Sale | -20,110 | -0.27%40,391 | $25.10 | $504,699 | View SEC filing | |
| 2025-12-22 | Galbraith Kenneth Chair & CEO | Sale | -47,528 | -26.29%133,275 | $27.02 | $1,284,311 | View SEC filing | |
| 2025-05-19 | NODELMAN OLEG Director, 10% Owner | Purchase | +55,421 | +0.31%17,883,908 | $11.47 | $635,586 | View SEC filing | |
| 2025-04-18 | NODELMAN OLEG Director, 10% Owner | Purchase | +128,713 | +0.73%17,828,487 | $11.32 | $1,456,408 | View SEC filing | |
| 2025-04-07 | NODELMAN OLEG Director, 10% Owner | Purchase | +317,208 | +1.82%17,699,774 | $11.42 | $3,623,970 | View SEC filing | |
| 2025-04-02 | NODELMAN OLEG Director, 10% Owner | Purchase | +127,415 | +0.74%17,382,566 | $11.75 | $1,497,322 | View SEC filing | |
| 2025-03-27 | NODELMAN OLEG Director, 10% Owner | Purchase | +97,349 | +0.57%17,255,151 | $12.61 | $1,227,309 | View SEC filing | |
| 2025-03-24 | NODELMAN OLEG Director, 10% Owner | Purchase | +127,198 | +0.75%17,157,802 | $12.92 | $1,643,248 | View SEC filing | |
| 2025-03-19 | NODELMAN OLEG Director, 10% Owner | Purchase | +228,463 | +1.36%17,030,604 | $12.55 | $2,866,553 | View SEC filing | |
| 2025-03-13 | NODELMAN OLEG Director, 10% Owner | Purchase | +1,081,980 | +6.88%16,802,141 | $12.13 | $13,120,914 | View SEC filing | |
| 2025-01-21 | EcoR1 Capital, LLC Director, 10% Owner | Purchase | +141,429 | +0.91%15,720,161 | $13.88 | $1,963,538 | View SEC filing | |
| 2025-01-15 | EcoR1 Capital, LLC Director, 10% Owner | Purchase | +167,654 | +1.09%15,578,732 | $13.59 | $2,278,811 | View SEC filing | |
| 2025-01-10 | EcoR1 Capital, LLC Director, 10% Owner | Purchase | +225,119 | +1.48%15,411,078 | $13.21 | $2,974,819 | View SEC filing | |
| 2025-01-06 | Moore Paul Andrew Chief Scientific Officer | Sale | -21,200 | -4.89%23,333 | $14.92 | $316,391 | View SEC filing | |
| 2025-01-06 | Galbraith Kenneth Chair & CEO | Sale | -57,291 | +13.13%80,803 | $14.92 | $855,017 | View SEC filing | |
| 2025-01-06 | Smith Jeffrey T L EVP & Chief Medical Officer | Sale | -11,110 | -55.55%8,890 | $14.92 | $165,807 | View SEC filing | |
| 2025-01-02 | EcoR1 Capital, LLC Director, 10% Owner | Purchase | +363,369 | +2.45%15,185,959 | $14.64 | $5,321,176 | View SEC filing | |
| 2024-12-27 | EcoR1 Capital, LLC Director, 10% Owner | Purchase | +130,309 | +0.89%14,822,590 | $14.44 | $1,882,115 | View SEC filing | |
| 2024-12-26 | EcoR1 Capital, LLC Director, 10% Owner | Purchase | +1,254,808 | +9.34%14,692,281 | $13.98 | $17,544,284 | View SEC filing |
1-25 of 42
